首页> 外文期刊>Journal of Cancer Research and Clinical Oncology >Oestrogen receptors are prognostic factors in malignant peritoneal mesothelioma
【24h】

Oestrogen receptors are prognostic factors in malignant peritoneal mesothelioma

机译:雌激素受体是恶性腹膜间皮瘤的预后因素

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background: Malignant peritoneal mesothelioma (MPM) is a rare and fatal cancer. Females are found to survive longer than males after treatment, suggesting a possible involvement of hormonal factors. Estradiol is involved in cellular proliferation of a number of cancers and acts mainly through oestrogen receptors (ERs). Hence, we examined the expression of oestrogen receptors with correlation to prognosis. Methods: Oestrogen receptors expression was examined using immunohistochemistry on 42 paraffin-embedded sections of MPM tumours. Kaplan-Meier survival curves were analysed to determine the significance of ER expression in relation to prognosis. Results: ER-β (nuclear) was detected in 33 (79 %) patients. ER-β was also detected in the cellular cytoplasm of 9 (21 %) patients. Presence of ER-β (nuclear) was associated with favourable survival (univariate analysis, P = 0.001), whereas the presence of ER-β (cytoplasm) was associated with a poor survival (P = 0.014). Multivariate Cox regression analysis revealed the absence of ER-β (nuclear) and the presence of ER-β (cytoplasm) to be independent predictive factors for poor disease outcome (hazard ratio 5.4, 95 % confidence interval 1.86-15.75; P = 0.002 and hazard ratio 8.0, 95 % confidence interval 1.8-34; P = 0.005), respectively. ER-α (nuclear) was detected in only 4 (9 %) of patients and not statistically significant (univariate analysis, P = 0.066). Conclusion: The presence of ER-β (cytoplasm) is associated with poor prognosis. The favourable survival association observed in patients with ER-β (nuclear) raises a question about the molecular mechanisms of the tumorigenic roles of ER-β in each cellular compartment and requires further studies.
机译:背景:恶性腹膜间皮瘤(MPM)是一种罕见且致命的癌症。发现女性在治疗后的生存时间比男性长,这表明可能与激素因素有关。雌二醇参与许多癌症的细胞增殖,并且主要通过雌激素受体(ER)起作用。因此,我们检查了雌激素受体的表达与预后的关系。方法:采用免疫组织化学方法检测42例MPM肿瘤石蜡包埋切片中雌激素受体的表达。分析Kaplan-Meier生存曲线以确定ER表达与预后的关系。结果:33(79%)患者中检测到ER-β(核)。在9名(21%)患者的细胞质中也检测到了ER-β。 ER-β(核)的存在与良好的生存率相关(单因素分析,P = 0.001),而ER-β(胞质)的存在与较差的生存率相关(P = 0.014)。多变量Cox回归分析显示,缺乏ER-β(核)和ER-β(细胞质)是疾病预后不良的独立预测因素(危险比5.4、95%置信区间1.86-15.75; P = 0.002和危险比分别为8.0、95%置信区间1.8-34; P = 0.005)。仅4(9%)患者检出ER-α(核),但无统计学意义(单因素分析,P = 0.066)。结论:ER-β(细胞质)的存在与预后不良有关。在ER-β(核)患者中观察到的良好的生存关联性提出了有关每个细胞区室中ER-β致瘤作用的分子机制的问题,需要进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号